Sort   by:  
 Page size 
UnknownPhase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603.
Not available
S-EPMC9355819 | biostudies-literature
UnknownStudy protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer.
Not available
S-EPMC9086607 | biostudies-literature
UnknownFMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
Not available
S-EPMC7780005 | biostudies-literature
UnknownGenetic insights into ossification of the posterior longitudinal ligament of the spine.
Not available
S-EPMC10353864 | biostudies-literature
Sort   by:  
 Page size